BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21980525)

  • 1. VEGFR2 translocates to the nucleus to regulate its own transcription.
    Domingues I; Rino J; Demmers JA; de Lanerolle P; Santos SC
    PLoS One; 2011; 6(9):e25668. PubMed ID: 21980525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
    Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
    Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation.
    Goyal A; Poluzzi C; Willis CD; Smythies J; Shellard A; Neill T; Iozzo RV
    J Biol Chem; 2012 Dec; 287(52):43543-56. PubMed ID: 23060442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
    Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization of the tyrosine kinase BMX mediates VEGFR2 expression.
    Liu T; Li Y; Su H; Zhang H; Jones D; Zhou HJ; Ji W; Min W
    J Cell Mol Med; 2020 Jan; 24(1):126-138. PubMed ID: 31642192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
    Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
    Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.
    Higgins KJ; Liu S; Abdelrahim M; Vanderlaag K; Liu X; Porter W; Metz R; Safe S
    Mol Endocrinol; 2008 Feb; 22(2):388-402. PubMed ID: 18006642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling, transcription factor SNAI2 and interleukin-8.
    Laakkonen JP; Lappalainen JP; Theelen TL; Toivanen PI; Nieminen T; Jauhiainen S; Kaikkonen MU; Sluimer JC; Ylä-Herttuala S
    Angiogenesis; 2017 Feb; 20(1):109-124. PubMed ID: 27873103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
    Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
    Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
    Willis CD; Poluzzi C; Mongiat M; Iozzo RV
    FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
    Loeffler S; Fayard B; Weis J; Weissenberger J
    Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins.
    Higgins KJ; Liu S; Abdelrahim M; Yoon K; Vanderlaag K; Porter W; Metz RP; Safe S
    Endocrinology; 2006 Jul; 147(7):3285-95. PubMed ID: 16574784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
    Higgins KJ; Abdelrahim M; Liu S; Yoon K; Safe S
    Biochem Biophys Res Commun; 2006 Jun; 345(1):292-301. PubMed ID: 16678129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.